Treatment of HNSCC cell lines with the EGFR-specific inhibitor cetuximab (Erbitux) results in paradox phosphorylation of tyrosine 1173 in the receptor (Q40244548)
Jump to navigation
Jump to search
scientific article published on 4 August 2006
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Treatment of HNSCC cell lines with the EGFR-specific inhibitor cetuximab (Erbitux) results in paradox phosphorylation of tyrosine 1173 in the receptor |
scientific article published on 4 August 2006 |
Statements
1 reference
Treatment of HNSCC cell lines with the EGFR-specific inhibitor cetuximab (Erbitux) results in paradox phosphorylation of tyrosine 1173 in the receptor (English)
1 reference
Jochen A Werner
1 reference
Robert Mandic
1 reference
Chantal J Rodgarkia-Dara
1 reference
Li Zhu
1 reference
Benedikt J Folz
1 reference
Michael Bette
1 reference
Eberhard Weihe
1 reference
Andreas Neubauer
1 reference
4 August 2006
1 reference
1 reference
580
1 reference
20
1 reference
4793-4800
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference